Skyline Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
ECSS
Skyline Advisors's MRK Position: Q2 2026 in Review
Skyline Advisors reduced its Merck (MRK) stake by 0.22% in Q2 2026, selling an estimated $585 and leaving 2,233 shares worth $287K. The position accounts for 0.09% of the portfolio, ranked #102.
Skyline Advisors first reported a position in MRK in Q4 2023 and has held it in 9 quarters since. The position peaked at $378K in Q1 2024. 1,737 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Skyline Advisors held 2,233 shares of Merck worth $287K as of Q2 2026.
- Skyline Advisors sold 5 Merck shares in Q2 2026, an estimated $585.
- Merck made up 0.09% of Skyline Advisors's portfolio in Q2 2026, its #102 holding.
- Skyline Advisors first reported a position in Merck in Q4 2023 and has held it in 9 quarters since.
- Skyline Advisors's Merck position peaked at $378K in Q1 2024.
- 1,737 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Skyline Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.